The invention relates to chromatographic separating materials having improved binding capacity for biological constituents in cell culture supernatants, or animal or human body fluids, in particular for monoclonal antibodies. The present invention likewise relates to the preparation of separating materials of this type, and to the use thereof, in particular for the removal of charged biopolymers from corresponding liquids.

The invention relates to a method for producing a solid nanocomposite material comprising nanoparticles of a metal coordination polymer with ligands CN, said nanoparticles satisfying the formula [Alk.sup.+.sub.x]M.sup.n+[M(CN).sub.m].sup.z? where Alk is an alkali metal, x is 1 or 2, M is a transition metal, n is 2 or 3, M is a transition metal, m is 6 or 8, and z is 3 or 4; said M.sup.n+ cations of the coordination polymer being bound by an organometallic bond or a coordination bond to an organic group R2 of an organic graft, and said organic graft furthermore being chemically attached, preferably by a covalent bond, to at least one surface of a solid support, by reaction of a group R1 of said graft with said surface.

The invention relates to a method for producing a solid nanocomposite material comprising nanoparticles of a metal coordination polymer with ligands CN, said nanoparticles satisfying the formula [Alk.sup.+.sub.x]M.sup.n+[M(CN).sub.m].sup.z? where Alk is an alkali metal, x is 1 or 2, M is a transition metal, n is 2 or 3, M is a transition metal, m is 6 or 8, and z is 3 or 4; said M.sup.n+ cations of the coordination polymer being bound by an organometallic bond or a coordination bond to an organic group R2 of an organic graft, and said organic graft furthermore being chemically attached, preferably by a covalent bond, to at least one surface of a solid support, by reaction of a group R1 of said graft with said surface.

In one aspect, a composite membrane comprises a polymeric host comprising polybenzimidazole or polybenzimidazole derivative and graphene oxide dispersed in the polymeric host, the graphene oxide at least partially functionalized with phosphonic acid moieties, phosphonate moieties or combinations thereof. In some embodiments, the functionalized graphene oxide is homogeneously dispersed in the polymeric host and/or is not agglomerated in the polymeric host.

In one aspect, a composite membrane comprises a polymeric host comprising polybenzimidazole or polybenzimidazole derivative and graphene oxide dispersed in the polymeric host, the graphene oxide at least partially functionalized with phosphonic acid moieties, phosphonate moieties or combinations thereof. In some embodiments, the functionalized graphene oxide is homogeneously dispersed in the polymeric host and/or is not agglomerated in the polymeric host.

The invention provides a method for the purification of 227 Th from a mixture comprising 227 Th and 223 Ra, said method comprising: i) preparing a first solution comprising a mixture of 227 Th and 223 Ra ions dissolved in a first aqueous buffer; ii) loading said first solution onto a separation material such as a strong cation exchange resin; iii) eluting 227 Th from the separation material, whereby to generate a second solution comprising 227 Th; iv) Optionally rinsing said separation material using a first aqueous washing medium; The invention additionally provides a method for forming a radio pharmaceutical comprising complexing the purified 227 Th, the pharmaceutical product and its use in treatment of disease such as cancer and a kit for generation of such a product.

The invention provides a method for the purification of 227 Th from a mixture comprising 227 Th and 223 Ra, said method comprising: i) preparing a first solution comprising a mixture of 227 Th and 223 Ra ions dissolved in a first aqueous buffer; ii) loading said first solution onto a separation material such as a strong cation exchange resin; iii) eluting 227 Th from the separation material, whereby to generate a second solution comprising 227 Th; iv) Optionally rinsing said separation material using a first aqueous washing medium; The invention additionally provides a method for forming a radio pharmaceutical comprising complexing the purified 227 Th, the pharmaceutical product and its use in treatment of disease such as cancer and a kit for generation of such a product.

The objects of embodiments in the present disclosure are to provide a method capable of recovering two or more amine compounds at the same time from a gas or solution, and also to provide a method capable of analyzing the recovered amines. The amine-recovering method comprises the steps (A) and (B). In the step (A), the gas or solution is brought into contact with a solid adsorbent so that the adsorbent may retain the amines. In the step (B), the amines retained by the adsorbent in the step (A) are eluted out by use of a basic compound-containing organic solvent. The solid adsorbent has a substituent group represented by SO.sub.3M (M is H or an alkali metal).

The objects of embodiments in the present disclosure are to provide a method capable of recovering two or more amine compounds at the same time from a gas or solution, and also to provide a method capable of analyzing the recovered amines. The amine-recovering method comprises the steps (A) and (B). In the step (A), the gas or solution is brought into contact with a solid adsorbent so that the adsorbent may retain the amines. In the step (B), the amines retained by the adsorbent in the step (A) are eluted out by use of a basic compound-containing organic solvent. The solid adsorbent has a substituent group represented by SO.sub.3M (M is H or an alkali metal).

A method of acid manufacturing using acid cation resins for recycling salt and/or salt products from wastes and/or waste waters utilizes a brine solution, an acid cation resin, an acid solution, and an ion exchanger. The acid cation resin is into hydrogen form with the acid solution within the ion exchanger. The acid cation resin is then washed using water with salinity to remove any excess acid from the exterior of the acid cation resin. A selected brine of salts is then prepared of the desired acid(s) to be produced. The desired acid is produced by contacting the acid cation resin containing cations in concentration with the selected brine. A second ion exchange reaction is executed to substitute hydrogen for cations in the selected brine.